India urges frontline workers not to refuse vaccines as targets missed

By: |
January 19, 2021 9:49 PM

Vinod K Paul, who heads a govt panel on coronavirus vaccine strategy, said health workers who failed to take vaccine doses were not fulfilling their ‘societal responsibility’.

Coronavirus, coronavirus vaccine in india, india vaccines, india covid vaccines, oxford vaccines, india covid mass vaccination, covishield, covaxin, bharat biotechSome doctors have expressed doubt about the Bharat Biotech vaccine, which was given approval for emergency use without efficacy data from late-stage clinical trials. (Photo: The Indian Express)

India appealed to frontline workers on Tuesday not to refuse vaccines for COVID-19, after almost all states failed to meet their targets in the first few days of one of the world’s biggest immunisation campaigns. The country has so far vaccinated 631,417 frontline workers with two shots manufactured locally, one developed by Oxford University and AstraZeneca, and another developed at home by Bharat Biotech in partnership with the state-run India Council of Medical Research. The programme started on Saturday, with 30 million healthcare and other front-line workers first in the queue.

The health ministry said India inoculated more people on its first day than the United States, Britain and France did. But it said it expected a greater number of volunteers to come forward, especially in major states like Tamil Nadu and Punjab that are lagging behind other states. Vinod K Paul, who heads a government committee on vaccine strategy, told a news conference that health workers who failed to take vaccine doses that had been set aside for them were not fulfilling their “societal responsibility”. “Please understand the whole world is clamouring for vaccines,” he said. “If our healthcare workers, our doctors and nurses, if they are declining to take it, I feel sorry,” he said.

“I plead with them, on behalf of the government, because we don’t know what shape this pandemic will take going forward. “Some doctors have expressed doubt about the Bharat Biotech vaccine, which was given approval for emergency use without efficacy data from late-stage clinical trials. The government says it is safe and effective. Paul said he had received his own shot of it on the first day. India, the world’s biggest vaccine maker, plans to start exporting shots as early as Wednesday.

Cases have come down in recent months. On Tuesday India reported 10,064 infections, the lowest in seven months, taking the total to 10.58 million. Deaths rose by an eight-month low figure of 137, taking the overall tally to 152,556.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus Live Updates: WHO lauds India’s decision to resume vax export; tension brews over AstraZeneca recognition in US
2US Congressman welcomes India’s decision to resume export of surplus Covid vaccine
3India’s cumulative Covid-19 vaccine coverage crosses 81.73 crore